Seattle Cardiorenal Remote Ischemic Preconditioning Trial (SCRIPT)
Effect of Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- Seattle Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Age birth to 18 years Cardiac surgery with planned cardiopulmonary bypass
Exclusion Criteria:
Any contraindication to compression of lower extremity/extremities Body weight <2 kg Active infection going into surgery On renal replacement therapy (RRT) or mechanical circulatory support going into surgery On inotropic support going into surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sham Comparator: Control
|
In OR, after induction of general anesthesia and arterial line placement, a deflated tourniquet will be placed over the lower extremity for 40 minutes.
|
|
Experimental: Remote Ischemic Preconditioning (RIPC)
|
RIPC will be elicited in the operating room (OR) after anesthesia induction and before start of surgery.
After placement of an arterial line, a tourniquet will be placed over a lower extremity.
It will be inflated to 15 mmHg above systolic blood pressure for 5 minutes, and then deflated for 5 minutes.
This cycle of inflation-deflation will be repeated another 3 times before surgery.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of acute kidney injury (AKI)
Time Frame: 72 hours
|
Serum creatinine (SCr) will be measured at baseline, then on post-operative days 1, 2, and 3.
|
72 hours
|
|
Incidence of acute myocardial injury
Time Frame: 48 hours
|
Troponin-I will be measured at baseline, then 6, 12, 24, and 48 hours post-operative.
|
48 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of acute lung injury
Time Frame: 72 hours and duration of hospitalization
|
Days on mechanical ventilation, readiness for extubation.
|
72 hours and duration of hospitalization
|
|
Hospitalization
Time Frame: Duration of post-operative hospitalization
|
Number of post-operative days in cardiac intensive care unit (CICU) and hospital.
|
Duration of post-operative hospitalization
|
|
Mortality
Time Frame: Duration of hospitalization, 30 days post-op, and at last follow-up
|
Duration of hospitalization, 30 days post-op, and at last follow-up
|
|
|
Biomarkers for AKI
Time Frame: 72 hours
|
Serum and urine will be collected for biomarker discovery.
|
72 hours
|
|
Inflammation
Time Frame: 72 hours
|
Cytokines will be measured at baseline until 72 hours post-operative.
|
72 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Christine W Hsu, MD, Seattle Children's Hospital and University of Washington
- Principal Investigator: Yuk Law, MD, Seattle Children's Hospital and University of Washington
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Kidney Diseases
- Urologic Diseases
- Congenital Abnormalities
- Renal Insufficiency
- Cardiovascular Abnormalities
- Thoracic Injuries
- Heart Diseases
- Wounds and Injuries
- Acute Kidney Injury
- Heart Defects, Congenital
- Acute Lung Injury
- Lung Injury
Other Study ID Numbers
Other Study ID Numbers
- CCTR-3953179
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.